Pharmaceutical Intermediates
- • Analgesics (56)
- • Anesthetics (52)
- • Anti-Addiction Agents (8)
- • Antibacterials (117)
- • Anticonvulsants (20)
- • Antidementia Agents (23)
- • Antidepressants (35)
- • Antiemetics (24)
- • Antifungals (24)
- • Antigout Agents (9)
- • Anti-inflammatory Agents (28)
- • Antimigraine Agents (21)
- • Antineoplastics (427)
- • Antiparasitics (11)
- • Antiparkinson Agents (28)
- • Antipsychotics (54)
- • Antispasticity Agents (12)
- • Antivirals (146)
- • Anxiolytics (16)
- • Blood Glucose Regulators (105)
- • Blood Products (61)
- • Cardiovascular Agents (179)
- • CNS Agents (22)
- • Dental and Oral Agents (8)
- • Dermatological Agents (19)
- • Electrolytes (15)
- • Gastrointestinal Agents (62)
- • Genetic/Enzyme Disorder (12)
- • Genitourinary Agents (47)
- • Immunological Agents (36)
- • Metabolic Bone Disease (6)
- • Ophthalmic Agents (32)
- • Respiratory Tract (51)
- • Skeletal Muscle Relaxants (5)
- • Sleep Disorder Agents (28)
- • Oled Material Intermediate (333)
- • Heterocyclic Compound (9758)
- • Bulk Drug Intermediates (17691)
Related News
Antiparasitics
4,4′-Dihydroxybiphenyl
(92-88-6)-
Pharmaceutical Grade / 99%
-
Pharmaceutical Grade / 99.9%
-
Pharmaceutical Grade / 99%
-
Pharmaceutical Grade / 99%
Request for quotation , get quotes from more suppliers.
More Information
Antiparasitics are designed to target a wide range of parasites, including protozoa, nematodes, cestodes, and ectoparasites. Their mechanisms vary: some disrupt parasite metabolism, others impair nervous system function or interfere with reproduction.
Commonly used antiparasitic agents include albendazole and mebendazole for intestinal worms, metronidazole for protozoal infections, and ivermectin or permethrin for ectoparasites. Selection depends on the type of parasite, host species, safety profile, and intended dosage form.
These raw materials are supplied in powder, crystalline, or solution forms suitable for tablets, capsules, injectables, or topical formulations, supporting both clinical therapy and research applications.
Frequently Asked Questions
Antiparasitics are medications used to treat infections caused by parasites, including protozoa, helminths (worms), and ectoparasites like lice and mites. They work by targeting specific biological processes in the parasite—such as disrupting nerve transmission, inhibiting energy metabolism, or damaging cell membranes—while minimizing harm to the host. Common classes include anthelmintics, antiprotozoals, and ectoparasiticides.
The most widely used antiparasitic drugs include:1. **Albendazole** and **Mebendazole** – effective against intestinal worms.2. **Ivermectin** – used for roundworm infections and ectoparasites like scabies.3. **Metronidazole** and **Tinidazole** – primarily target protozoan infections such as giardiasis and trichomoniasis.4. **Praziquantel** – the drug of choice for schistosomiasis and tapeworm infections.Each type is selected based on the parasite species, infection site, and patient factors.
When selecting a supplier for antiparasitic active pharmaceutical ingredients (APIs) or finished formulations, consider:1. Regulatory compliance (e.g., FDA, EMA, WHO-GMP certifications).2. Quality assurance systems, including documentation of purity, stability, and impurity profiles.3. Manufacturing capacity and supply chain reliability.4. Technical support and regulatory dossier availability (e.g., DMF, CEP).Reputable suppliers should provide full traceability and adhere to international pharmacopeial standards (USP, EP, etc.).
Yes, antiparasitics approved for human use are generally safe when administered according to prescribed guidelines. However, like all medications, they can cause side effects—ranging from mild (nausea, dizziness) to rare but serious reactions (hepatotoxicity, neurotoxicity). Safety depends on correct dosing, patient age, pregnancy status, and potential drug interactions. Always use under medical supervision and avoid off-label use without clinical justification.
Antiparasitics play a critical role in global public health initiatives, including:1. Mass drug administration (MDA) programs to control neglected tropical diseases (NTDs) like lymphatic filariasis, onchocerciasis, and soil-transmitted helminthiasis.2. Treatment of malaria (using antiprotozoal agents like artemisinin derivatives).3. Outbreak response for parasitic infections in humanitarian crises.4. Veterinary public health, where controlling zoonotic parasites reduces human transmission risk.These applications significantly reduce morbidity and mortality in endemic regions.